|The IGFBP6 igfbp6 (Catalog #MBS651036) is a Recombinant Protein produced from Yeast and is intended for research purposes only. The product is available for immediate purchase.
The IGFBP6 igfbp6 product has the following accession number(s) (GI #11321593) (NCBI Accession #NP_002169.1) (Uniprot Accession #P24592). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Our knowledge of the role of proteins in cellular processes is continually evolving. Most proteins, including Insulin-Like Growth Factor Binding Protein 6 are typically involved in one or more signaling pathways or biological processes. Professionally manufactured recombinant proteins are increasingly becoming essential and commonplace tools for elucidating new knowledge about the role of proteins in both health and disease.
Biological Activity: Binding activity of human IGF-BP 6 is determined by the inhibition activity of both IGF I and II. IGFBP6 also interacts with the following gene(s): IGF1, IGF2. The following patways have been known to be associated with this gene. Bone, Brain, Liver, Lung, Nerve, Ovary, Prostate, Skin, Thyroid, Uterus tissues are correlated with this protein. Adenocarcinoma, Carcinoma, Endocrine Gland Neoplasms, Female Urogenital Diseases, Genital Neoplasms, Female, Gonadal Disorders, Head and Neck Neoplasms, Insulin Resistance, Neoplasms, Thyroid Neoplasms are some of the diseases may be linked to Insulin-Like Growth Factor Binding Protein 6, Recombinant, Human (IGFBP6, IGF Binding Protein 6, IBP6).